936500-99-1

Basic information

• Product Name: 3-(4-AMinophenyl)-6,7-difluoroquinazoline- 2,4(1H,3H)-dione hydrochloride
• Synonyms: 3-(4-AMinophenyl)-6,7-difluoroquinazoline- 2,4(1H,3H)-dione hydrochloride;3-(4-AMinophenyl)-6,7-difluoro-2,4(1H,3H)-quinazolinedione hydrochloride (1:1);2,4(1H,3H)-Quinazolinedione, 3-(4-aminophenyl)-6,7-difluoro-, hydrochloride (1:1 );3-(4-Amino-phenyl)-6,7-difluoro-1H-quinazoline-2,4-dione;3-(4-aminophenyl)-6,7-difluoroquinazoline-2,4(1H,3H)-dione
• CAS NO: 936500-99-1
• Molecular Formula: C₁₄H₉F₂N₃O₂*ClH
• Molecular Weight: 325.6979064
• EINECS: -0
• Mol File: 936500-99-1.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-(4-AMinophenyl)-6,7-difluoroquinazoline- 2,4(1H,3H)-dione hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(4-AMinophenyl)-6,7-difluoroquinazoline- 2,4(1H,3H)-dione hydrochloride(936500-99-1)
• EPA Substance Registry System: 3-(4-AMinophenyl)-6,7-difluoroquinazoline- 2,4(1H,3H)-dione hydrochloride(936500-99-1)

Safety Data

• Hazardous Substances Data: 936500-99-1(Hazardous Substances Data)

Usage

Chemical Classification

Quinazoline derivative

Physical Appearance

White to off-white, crystalline powder

Solubility

Sparingly soluble in water

Primary Use

Research and development of pharmaceuticals

Specific Application

Potential antineoplastic agent in cancer treatment

Additional Applications

Biochemical tool in studying biological processes and pathways

Potential

Promising in drug discovery and medical research

Limitations

Requires further study to understand its full biological activity and therapeutic potential

Upstream product

• 207346-42-7 2-amino-4,5-difluoro-benzoic acid,methyl ester 
• 207346-43-8 C₁₅H₁₀F₂N₂O₆ 
• 936500-98-0 C₁₉H₁₇F₂N₃O₄ 

Downstream Products

• 936500-94-6 Elinogrel 
• 1079989-98-2 [4-(6-chloro-7-methylamino-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea tromethamine salt 
• 1079989-95-9 [4-(6-chloro-7-methylamino-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea L-lysine salt 
• 1079989-99-3 [4-(6-chloro-7-methylamino-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea N-ethylglucamine salt 
• 936501-00-7 3-(4-aminophenyl)-6-fluoro-7-(methylamino)quinazoline-2,4(1H,3H)-dione 

Relevant articles and documents

[4-(6-FLUORO-7-METHYLAMINO-2,4-DIOXO-1,4-DIHYDRO-2H-QUINAZOLIN-3-YL)-PHENYL]-5-CHLORO-THIOPHEN-2-YL-SULFONYLUREA SALTS, FORMS AND METHODS RELATED THERETO

The present invention provides novel sulfonylurea salts of a salt of formula (I) and polymorph forms thereof. The compounds in their various forms are effective platelet ADP receptor inhibitors and may be used in various pharmaceutical compositions, and a